Hairy cell leukemia
What is Hairy cell leukemia?
Hairy cell leukemia is a rare type of blood cancer that grows slowly. It affects B cells, a type of white blood cell that helps fight infections. The cancer cells have unusual projections that look like hair under a microscope, which gives the disease its name.
This condition causes abnormal B cells to build up in your bone marrow and spleen. Your bone marrow is the spongy tissue inside your bones that makes blood cells. As hairy cells crowd out healthy cells, your body struggles to make enough normal blood cells. This leads to low counts of red blood cells, white blood cells, and platelets.
Hairy cell leukemia affects about 2 people per million each year. It most commonly appears in middle-aged men, with 4 times more men diagnosed than women. Most people are diagnosed between ages 50 and 60. The good news is that this cancer usually responds well to treatment, and many people live for decades after diagnosis.
Symptoms
- Feeling tired or weak all the time
- Frequent infections that are hard to shake
- Easy bruising or bleeding, including nosebleeds
- Shortness of breath during normal activities
- Feeling full quickly when eating
- Pain or fullness in the upper left abdomen from an enlarged spleen
- Unintended weight loss
- Night sweats
- Swollen lymph nodes
- Pale skin
Many people with hairy cell leukemia have no symptoms early on. The condition is often found during routine blood work done for other reasons. Symptoms usually develop slowly over months or years as abnormal cells gradually replace healthy ones.
Concerned about Hairy cell leukemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
The exact cause of hairy cell leukemia remains unknown. Scientists know that nearly all cases involve a specific change in the BRAF gene called the V600E mutation. This genetic change happens during your lifetime and is not inherited from your parents. The mutation causes B cells to grow out of control and live longer than normal. Why this mutation occurs in the first place is still being studied.
Risk factors for hairy cell leukemia are not well understood due to its rarity. Being male increases your risk, as does being middle-aged or older. Some research has explored possible links to radiation exposure, farming chemicals, and certain viral infections like HTLV-II. However, most people with hairy cell leukemia have no known risk factors. Family history does not appear to play a major role in this disease.
How it's diagnosed
Doctors diagnose hairy cell leukemia through several steps. First, a complete blood count often shows low levels of red blood cells, white blood cells, and platelets. A blood smear examined under a microscope may reveal the characteristic hairy cells. However, a bone marrow biopsy provides the definitive diagnosis. During this procedure, a doctor removes a small sample of bone marrow to examine for hairy cells.
Specialized tests help confirm the diagnosis and guide treatment. BRAF mutation analysis looks for the V600E mutation found in nearly all hairy cell leukemia cases. Flow cytometry identifies specific proteins on cell surfaces that are unique to hairy cells. Some doctors may also test for HTLV-II DNA, as research continues to explore possible viral connections. These specialized tests require laboratory expertise beyond standard blood panels. Talk to your doctor about which tests are right for your situation.
Treatment options
- Active surveillance with regular monitoring if you have no symptoms
- Chemotherapy with drugs like cladribine or pentostatin, which are highly effective
- Targeted therapy with vemurafenib for cases with BRAF mutations
- Rituximab, an antibody therapy that targets cancer cells
- Spleen removal in rare cases when the spleen is severely enlarged
- Infection prevention through good hygiene and avoiding sick contacts
- Blood transfusions if your counts become dangerously low
- Growth factors to stimulate blood cell production
- Regular follow-up visits to monitor for relapse
Frequently asked questions
Hairy cell leukemia is rare and grows very slowly compared to other leukemias. The cancer cells have distinctive hair-like projections visible under a microscope. Nearly all cases have a specific BRAF gene mutation that helps with diagnosis. This type of leukemia also responds exceptionally well to treatment, with many patients achieving long-term remission.
Many people with hairy cell leukemia live for decades after diagnosis. The 10-year survival rate is around 95 percent or higher with modern treatments. Some patients achieve complete remission and never have symptoms again. Even if the disease returns, it usually responds well to additional treatment.
Not everyone needs immediate treatment after diagnosis. Doctors often recommend active surveillance if you have no symptoms and normal blood counts. Treatment typically starts when blood counts drop significantly, the spleen becomes very enlarged, or frequent infections occur. Your doctor will monitor you regularly to determine the right time to begin therapy.
The BRAF mutation is a genetic change found in nearly all hairy cell leukemia cases. It causes cells to grow and divide uncontrollably. Testing for this mutation helps doctors confirm the diagnosis and can guide treatment decisions. Some newer drugs specifically target cells with this mutation, offering more treatment options.
While doctors avoid using the word cure, many patients achieve complete remission with treatment. Remission means no detectable cancer cells remain in your body. Some people stay in remission for the rest of their lives. Even if the disease returns, it usually responds well to treatment again.
First-line treatment usually involves chemotherapy drugs like cladribine or pentostatin. These drugs are given through an IV over several days. Most patients need only one course of treatment to achieve remission. Targeted therapies and antibody treatments offer additional options if needed.
Monitoring schedules depend on whether you are on active surveillance or in remission after treatment. If watching and waiting, you might see your doctor every 3 to 6 months for blood work and exams. After successful treatment, checkups may be every 3 to 12 months. Your doctor will adjust the schedule based on your individual situation.
Focus on supporting your immune system and overall health. Eat a nutrient-dense diet rich in fruits, vegetables, and lean proteins. Get adequate sleep and manage stress through activities like walking or meditation. Avoid people who are sick and practice good hand hygiene to prevent infections.
Hairy cells crowd out normal cells in your bone marrow. This prevents your body from making enough healthy red blood cells, white blood cells, and platelets. The enlarged spleen may also trap and destroy blood cells. These low counts cause many of the symptoms like fatigue, infections, and easy bruising.
Hairy cell leukemia is not considered hereditary. The BRAF mutation that causes it occurs during your lifetime and is not passed from parents to children. Family history does not appear to increase your risk. The disease develops due to acquired genetic changes rather than inherited ones.